MeSH term
Frequency | Condition_Probility | Gene Therapy | 3 | 0.0 |
Humans | 50 | 0.0 |
Adenoviridae/*genetics | 4 | 1.0 |
Animals | 27 | 0.0 |
Cell Line | 14 | 0.0 |
DNA, Recombinant/genetics | 2 | 3.0 |
Female | 8 | 0.0 |
Gene Expression | 7 | 0.0 |
Hela Cells | 7 | 0.0 |
Liver/metabolism | 2 | 0.0 |
Mice | 7 | 0.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Blotting, Western | 3 | 0.0 |
Mutation | 6 | 0.0 |
beta-Galactosidase/biosynthesis | 2 | 4.0 |
Adenovirus E3 Proteins/*genetics | 2 | 50.0 |
Adenoviruses, Human/*genetics | 6 | 3.0 |
Amino Acid Sequence | 14 | 0.0 |
Genome, Viral | 4 | 3.0 |
Molecular Sequence Data | 16 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Rabbits | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 27 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Viral Proteins/*genetics | 2 | 2.0 |
CHO Cells | 3 | 0.0 |
Capsid/chemistry/genetics/*metabolism | 2 | 40.0 |
*Capsid Proteins | 15 | 12.0 |
Cloning, Molecular | 4 | 0.0 |
Hamsters | 7 | 0.0 |
Protein Binding | 2 | 0.0 |
Receptors, Virus/genetics/*metabolism | 2 | 6.0 |
*Transduction, Genetic | 2 | 2.0 |
Crystallography, X-Ray | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Protein Conformation | 4 | 0.0 |
Serotyping | 9 | 4.0 |
Adenoviruses, Human/genetics/*metabolism | 3 | 20.0 |
DNA, Viral | 4 | 2.0 |
Kinetics | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Genetic Vectors | 6 | 0.0 |
Binding Sites | 3 | 0.0 |
B-Lymphocytes/*virology | 2 | 14.0 |
Base Sequence | 10 | 0.0 |
Cell Line, Transformed | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
*Genetic Vectors | 6 | 1.0 |
N-Acetylneuraminic Acid/*physiology | 2 | 100.0 |
Receptors, Virus/*physiology | 2 | 5.0 |
Adenoviridae/*metabolism | 2 | 20.0 |
Carbocyanines | 2 | 11.0 |
Fluorescent Dyes | 2 | 0.0 |
In Vitro | 3 | 0.0 |
Rats | 5 | 0.0 |
*Adenoviridae | 3 | 9.0 |
Cystic Fibrosis Transmembrane Conductance Regulator/genetics | 2 | 3.0 |
*Gene Transfer Techniques | 3 | 0.0 |
Recombination, Genetic | 3 | 0.0 |
Biological Transport | 2 | 0.0 |
Genes, Viral | 7 | 3.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Adenoviruses, Human | 2 | 12.0 |
Viral Structural Proteins | 2 | 40.0 |
Gene Deletion | 2 | 0.0 |
Adenoviruses, Human/classification/*genetics | 2 | 50.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Epitopes/genetics | 3 | 3.0 |
Neutralization Tests | 3 | 0.0 |
Transduction, Genetic | 3 | 0.0 |
Capsid/*genetics | 3 | 15.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Infant | 2 | 0.0 |
Histocompatibility Antigens Class II/analysis | 2 | 1.0 |
Immunohistochemistry | 2 | 0.0 |
Cytopathogenic Effect, Viral | 2 | 1.0 |
Microbial Sensitivity Tests | 2 | 0.0 |
*Phosphonic Acids | 2 | 4.0 |
Adenoviruses, Human/*genetics/physiology | 3 | 25.0 |
DNA Replication | 2 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Virus Replication | 4 | 0.0 |
Cells, Cultured | 7 | 0.0 |
Endothelium, Vascular | 2 | 4.0 |
Genes, MHC Class I | 3 | 2.0 |
Male | 5 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
Plasmids | 2 | 0.0 |
Cattle | 2 | 0.0 |
Comparative Study | 9 | 0.0 |
Adenovirus Early Proteins | 4 | 5.0 |
Phosphorylation | 2 | 0.0 |
Molecular Weight | 3 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
*Genes, Viral | 3 | 1.0 |
Species Specificity | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
*Cell Transformation, Viral | 2 | 1.0 |
Adenoviridae/*physiology | 2 | 10.0 |
Gene Expression Regulation | 2 | 0.0 |
*DNA Replication | 2 | 0.0 |
Genetic Complementation Test | 2 | 0.0 |
*Virus Replication | 2 | 0.0 |
Enzyme Activation | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Bacteriophage lambda/genetics | 2 | 4.0 |
Chick Embryo | 2 | 0.0 |
DNA Restriction Enzymes | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
DNA, Viral/*analysis | 2 | 2.0 |
Flow Cytometry | 2 | 0.0 |
